Feridex-labeled mesenchymal stem cells: cellular differentiation and MR assessment in a canine myocardial infarction model

Acad Radiol. 2005 May:12 Suppl 1:S2-6. doi: 10.1016/j.acra.2005.02.014.
No abstract available

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Cell Differentiation / drug effects
  • Cells, Cultured
  • Chondrogenesis / drug effects
  • Contrast Media / pharmacokinetics
  • Contrast Media / toxicity
  • Dextrans
  • Dogs
  • Ferrosoferric Oxide
  • Humans
  • Iron / pharmacokinetics
  • Iron / toxicity
  • Magnetic Resonance Imaging / methods*
  • Magnetite Nanoparticles
  • Mesenchymal Stem Cells / chemistry*
  • Mesenchymal Stem Cells / drug effects
  • Myocardial Infarction / pathology
  • Myocardial Infarction / therapy*
  • Oxides / pharmacokinetics
  • Oxides / toxicity
  • Polylysine / pharmacology
  • Staining and Labeling / methods
  • Swine

Substances

  • Contrast Media
  • Dextrans
  • Magnetite Nanoparticles
  • Oxides
  • Polylysine
  • Iron
  • ferumoxides
  • Ferrosoferric Oxide